A systematic analysis of biotech startups that went public in the first half of 2021

Biotechnologies are being commercialized at historic rates. In 2020, 74 biotech startups went public through an initial offering (IPO) and 60 the IPO process in first six months of 2021. However, traits associated with obtaining recent IPOs have not been reported. this study, we built a database biotechs that underwent half After analyzing leadership, technological focus, clinical trials, financing these startups, found advanced degrees intellectual property were important factors for startups. The data also suggested large private rounds could decrease time-to-IPO affect post-IPO stock performance. particular, often exhibited by 108 2018–2019, thereby suggesting obtained 2021 necessarily driven COVID-19.